Expression of glucagon-like peptide 1 receptor in neuropeptide Y neurons of the arcuate nucleus in mice

被引:6
|
作者
Ruska, Yvette [1 ]
Szilvasy-Szabo, Anett [1 ]
Kovari, Dora [1 ,2 ]
Kadar, Andrea [1 ]
Macsai, Lilla [3 ]
Sinko, Richard [2 ,3 ]
Hrabovszky, Erik [4 ]
Gereben, Balazs [3 ]
Fekete, Csaba [1 ,5 ]
机构
[1] Inst Expt Med, Lab Integrat Neuroendocrinol, Szigony St 43, H-1083 Budapest, Hungary
[2] Semmelweis Univ, Janos Szentagothai Doctoral Sch Neurosci, H-1085 Budapest, Hungary
[3] Inst Expt Med, Lab Mol Cell Metab, H-1083 Budapest, Hungary
[4] Inst Expt Med, Lab Reprod Neurobiol, H-1083 Budapest, Hungary
[5] Tufts Med Ctr, Tupper Res Inst, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02111 USA
关键词
Glucagon-like peptide 1 receptor; Neuropeptide Y; Arcuate nucleus; Energy homeostasis; BRAIN; GLP-1; LOCALIZATION; APPETITE; AGONISTS; WEIGHT;
D O I
10.1007/s00429-021-02380-y
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Glucagon-like peptide 1 (GLP-1) and its agonists exert anorexigenic effect at least partly via acting on GLP-1 receptors (GLP-1R) in the arcuate nucleus (ARC). While the anorexigenic, proopiomelanocortin (POMC) neurons of the ARC were shown previously to express GLP-1R, the putative GLP-1R-content of the orexigenic, neuropeptide Y (NPY) neurons remained so far undetected. As GLP-1R is abundant in the ventromedial ARC, where NPY neurons are located; here, we address the possibility that GLP-1 can act directly on the orexigenic NPY system via GLP-1R. Double-labeling immunocytochemistry and in situ hybridization were performed on tissues of adult male mice to detect GLP-1R in NPY neurons. In double-immunolabeled preparations, GLP-1R-immunoreactivity was observed in NPY neurons and in axons ensheathing the majority of NPY neurons. Ultrastructural studies confirmed that GLP-1R-immunoreactivity is associated with the outer membrane of NPY perikarya as well as with axons forming symmetric type, inhibitory synapses on NPY-containing neurons. Double-labeling in situ hybridization experiments demonstrated the expression of GLP-1R mRNA in approximately 20% of NPY mRNA-containing neurons of the ARC. In summary, our data demonstrate the presence of GLP-1R protein and mRNA in NPY neurons of ARC and also reveal the innervation of NPY neurons by GLP-1R-containing inhibitory neurons. These observations suggest that GLP-1 signaling can influence NPY neurons both directly and indirectly. Furthermore, GLP-1 signaling on energy homeostasis appears to involve both direct and indirect effects of GLP-1 on the orexigenic NPY neurons, in addition to the previously known effects via the anorexigenic POMC neuronal system. [GRAPHICS] .
引用
收藏
页码:77 / 87
页数:11
相关论文
共 50 条
  • [31] The contribution of serotonin 5-HT2C and melanocortin-4 receptors to the satiety signaling of glucagon-like peptide 1 and liragultide, a glucagon-like peptide 1 receptor agonist, in mice
    Nonogaki, Katsunori
    Suzuki, Marina
    Sanuki, Mann
    Wakameda, Mamoru
    Tamari, Tomohiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 411 (02) : 445 - 448
  • [32] Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients
    ten Kulve, Jennifer S.
    van Bloemendaal, Liselotte
    Balesar, Rawien
    IJzerman, Richard G.
    Swaab, Dick F.
    Diamant, Michaela
    la Fleur, Susanne E.
    Alkemade, Anneke
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (05) : 2122 - 2129
  • [33] The glucagon-like peptide 2 receptor is expressed in enteric neurons and not in the epithelium of the intestine
    Pedersen, Jens
    Pedersen, Nis B.
    Brix, Sophie W.
    Grunddal, Kaare Villum
    Rosenkilde, Mette M.
    Hartmann, Bolette
    Orskov, Cathrine
    Poulsen, Steen S.
    Holst, Jens J.
    PEPTIDES, 2015, 67 : 20 - 28
  • [34] How glucagon-like peptide 1 receptor agonists work
    Andreasen, Christine Rode
    Andersen, Andreas
    Knop, Filip Krag
    Vilsboll, Tina
    ENDOCRINE CONNECTIONS, 2021, 10 (07) : R200 - R212
  • [35] Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection
    Harkavyi, Alexander
    Whitton, Peter S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (03) : 495 - 501
  • [36] Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor
    Kimura, Tomohiko
    Obata, Atsushi
    Shimoda, Masashi
    Okauchi, Seizo
    Hirukawa, Hidenori
    Kohara, Kenji
    Kinoshita, Tomoe
    Nogami, Yuka
    Nakanishi, Shuhei
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (06) : 540 - 548
  • [37] Cardioprotective Effects of Glucagon-Like Peptide 1 Receptor Agonists
    Ametov, A. S.
    Kamynina, L. L.
    Akhmedova, Z. G.
    KARDIOLOGIYA, 2014, 54 (07) : 92 - 96
  • [38] Glucagon-like peptide-1 receptor action in the vasculature
    Almutairi, Malak
    Al Batran, Rami
    Ussher, John R.
    PEPTIDES, 2019, 111 : 26 - 32
  • [39] Histological analysis of glucagon-like peptide-1 receptor expression in chicken pancreas
    Watanabe, Takafumi
    Nishimura, Kei
    Hosaka, Yoshinao Z.
    Shimosato, Takeshi
    Yonekura, Shinichi
    Suzuki, Daisuke
    Takemoto, Chihiro
    Monir, Mohammad Moniruzzaman
    Hiramatsu, Kohzy
    CELL AND TISSUE RESEARCH, 2014, 357 (01) : 55 - 61
  • [40] Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells
    Schlatter, P.
    Beglinger, C.
    Drewe, J.
    Gutmann, H.
    REGULATORY PEPTIDES, 2007, 141 (1-3) : 120 - 128